Skip to main
EPZM
EPZM logo

Epizyme (EPZM)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Epizyme (EPZM) Stock

About Epizyme (EPZM)

Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm als...read more
Market cap$247.44M
Today's volume
Revenue (TTM)
Avg. daily volume3.98M
EBITDA (TTM)
Open
Price / earnings ratio-0.85x
Today's range
Debt / equity
52 week range$0.41 - $5.8
5 year debt / equity-212.41x
Beta (LTM)1.56x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsAug 9, 2022
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 17, 2025, the market cap for Epizyme stock is $247.45M

The current P/E ratio for Epizyme stock is -0.85

The 52-week high for Epizyme stock is $5.80. The current Epizyme stock price $undefined is 100.00% below its 52-week high

The 52-week low for Epizyme stock is $0.41. The current Epizyme stock price $undefined has increased 100.00% from its 52-week low

No, the Epizyme stock does not pay dividends to its shareholders

How to buy Epizyme stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in Epizyme stock

    Navigate to the Explore page. Then, type Epizyme into the search bar. When you see Epizyme stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased Epizyme stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Epizyme Stock Earnings

The value each EPZM share was expected to gain vs. the value that each EPZM share actually gained.

Epizyme (EPZM) reported Q2 2022 earnings per share (EPS) of -$0.21, beating estimates of -$0.36 by 41.67%. In the same quarter last year, Epizyme's earnings per share (EPS) was -$0.63. Epizyme is expected to release next earnings on 08/09/2022, with an earnings per share (EPS) estimate of $0.

Buy Epizyme (EPZM) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.